Brand Asset Management Group, Inc. Astrazeneca PLC Transaction History

Brand Asset Management Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 24, 2019	SELL	$37.28 - $41.68 $4,249 - $4,751	-114 Closed	0 $0
Q1 2019 Apr 25, 2019	BUY	$35.49 - $43.02 $4,045 - $4,904	114 New	114 $5,000
Q4 2018 Jan 24, 2019	SELL	$36.86 - $41.49 $30,262 - $34,063	-821 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$34.55 - $37.05 $28,365 - $30,418	821 New	821 $29,000

1,380

476M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $209B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Brand Asset Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Brand Asset Management Group, Inc. with notifications on news.